Drug intelligence / Profile preview

chlormidazole

Development stage: Unknown
Lead developer: Grünenthal
Modality: Small Molecules
Administration: Topical

Overview

Chlormidazole is a synthetic antifungal agent belonging to the benzimidazole class of organic compounds. It contains a benzene ring fused to an imidazole ring and is classified under ATC code D01AC04. Chlormidazole acts as an antifungal by interfering with fungal cell processes, though its precise mechanism of action is not detailed in the available sources. It is structurally related to other imidazoles and benzimidazoles, which are known for their activity against fungal infections[2].

Beyond the preview

Go deeper on chlormidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlormidazole.

Explore the full profile